NewsRegulations & Policy

CDSCO gives nod to Glenmark’s acne drug Tazarotene

Tazarotene is a vitamin A derivative that acts by slowing down skin cell growth and blocking certain substances

The Central Drugs Standard Control Organization (CDSCO) committee has given its nod to Glenmark Pharma for the manufacturing and marketing of 

Tazarotene Lotion 0.045%, the formulation to treat acne. The nod was given by the Subject Expert Committee (SEC) during the 56th SEC meeting (Dermatology & Allergy) in New Delhi.

Tazarotene 0.05 %W/W is sold by Glenmark Pharma under the brand name TAZRET GEL 15GM to treat acne or pimples and psoriasis.

Tazarotene is a vitamin A derivative that acts by slowing down skin cell growth and blocking certain substances that cause skin inflammation (redness and swelling). This removes acne and eliminates scaling and thickening of the skin in psoriasis.

The committee noted that the product is approved internationally for the past several years. Tazarotene Cream and Gel 0.05% has been approved in India for many years.

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.

Tags

Related Articles

Leave a Reply

Back to top button
Close
Close